Testosterone Cypionate
Testosterone Cypionate is a pharmaceutical drug with 25 clinical trials. Currently 10 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
18
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
8 of 12 finished
33.3%
4 ended early
10
trials recruiting
25
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Clinical Trials (25)
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
Testosterone Replacement to Alleviate Pain in Postmenopausal Women (TRAPP Trial)
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
The COSMYC Trial (COmbined Suppression of MYC)
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
The Anabolic Effect of Testosterone on Pelvic Floor Muscles
COMbination of Bipolar Androgen Therapy and Nivolumab
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
Effect of Transgender Therapy on Muscle, Fat and Tissue Receptors
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy
RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study)
Can Testosterone Accelerate Injury Recovery After Arthroscopic Rotator Cuff Repair
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 25